Causaly

Causaly is a private, venture-backed AI/ML platform company founded in 2018, headquartered in London. It has developed a production-grade generative AI platform that integrates a massive, causality-focused knowledge graph with a scientific RAG (Retrieval-Augmented Generation) system and an enterprise data fabric. The company targets large life sciences organizations, offering tools for target identification, biomarker discovery, and disease research, with a strong emphasis on explainability, data security, and enterprise deployment. Its value proposition centers on transforming external and internal biomedical data into a unified, actionable 'single source of truth' for R&D teams.

Enterprise AI platform combining a high-precision, causality-focused biomedical knowledge graph (500M+ relationships) with a Scientific RAG™ system, a generative AI copilot, and an enterprise data fabric for integrating internal and external data.

Causaly competes in the AI-for-drug-discovery space against other knowledge graph and NLP companies like Elsevier (Entellect), IBM Watson Health, and startups such as BenevolentAI, Recursion, and Atomwise. Its key differentiators are its claimed focus on causality (not association), the transparency of its cited Copilot, and its enterprise-ready data fabric for internal IP integration.